{
    "eid": "2-s2.0-85089453513",
    "title": "Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn\u2019s disease using real world evidence in Thailand",
    "cover-date": "2020-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "biosimilar",
        "Cost-effectiveness analysis",
        "Crohn's disease",
        "infliximab",
        "Thailand"
    ],
    "authors": [
        "Pochamana Phisalprapa",
        "Chayanis Kositamongkol",
        "Julajak Limsrivilai",
        "Satimai Aniwan",
        "Phunchai Charatcharoenwitthaya",
        "Pises Pisespongsa",
        "Taya Kitiyakara",
        "Suporn Treepongkaruna",
        "Nathorn Chaiyakunapruk"
    ],
    "citedby-count": 2,
    "ref-count": 44,
    "ref-list": [
        "Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn\u2019s Disease Activity Index in Crohn\u2019s disease and measures of utility",
        "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies",
        "Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study",
        "The incidence and prevalence of Crohn\u2019s disease in global scale",
        "Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific",
        "Crohn\u2019s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis",
        "Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn\u2019s disease",
        "Systematic review with meta-analysis: recurrence of Crohn\u2019s disease after total colectomy with permanent ileostomy",
        "ACG clinical guideline: management of Crohn\u2019s disease in adults",
        "British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults",
        "3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn\u2019s Disease 2016: part 1: diagnosis and medical management",
        "Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a French equivalence study",
        "Biological therapies in Crohn\u2019s disease: are they cost-effective? A critical appraisal of model-based analyses",
        "A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease",
        "The cost-effectiveness of infliximab in Crohn\u2019s disease",
        "A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-\u03b1) inhibitors, adalimumab and infliximab, for Crohn\u2019s disease",
        "Thai Health Technology Accessment Guideline",
        "The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis",
        "Maintenance of remission among patients with Crohn\u2019s disease on antimetabolite therapy after infliximab therapy is stopped",
        "Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn\u2019s Disease in Sustained Remission",
        "Cost-effectiveness of biological therapy for Crohn\u2019s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data",
        "Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review",
        "A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease",
        "Outcomes after primary infliximab treatment failure in inflammatory bowel disease",
        "High-dose infliximab therapy in Crohn\u2019s disease: clinical experience, safety, and efficacy",
        "Clinical course and costs of care for Crohn\u2019s disease: Markov model analysis of a population-based cohort",
        "Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis",
        "Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial",
        "Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry",
        "Measurement of costs",
        "Handling uncertainty of the economic evaluation result: sensitivity analysis",
        "A health economic analysis of combination therapy with infliximab plus elemental diet for moderately to severely active Crohn\u2019s disease",
        "Systematic review: cost-effective strategies of optimizing anti-tumor necrosis and immunomodulators in inflammatory bowel disease",
        "Cost-utility of biological treatment sequences for luminal Crohn\u2019s disease in Europe",
        "The Cost-effectiveness of initial immunomodulators or infliximab using modern optimization strategies for Crohn\u2019s disease in the biosimilar era",
        "Health intervention and technology assessment in support of universal health coverage"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60011189",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Salt Lake City",
            "@id": "60025488",
            "affilname": "The University of Utah",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025488",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ministry of Public Health",
        "Faculty of Medicine, Chulalongkorn University",
        "Faculty of Medicine Siriraj Hospital, Mahidol University"
    ]
}